Drug delivery technology development in Canada / / special issue editors, Kishor M. Wasan, Ildiko Badea

• Pubblicazione: MDPI - Multidisciplinary Digital Publishing Institute, 2019
• Descrizione fisica: 1 electronic resource (352 p.)
• Disciplina: 615.1/900971
• Soggetto topico: Drug Delivery Systems - Canada
• Soggetto non controllato: encapsulation; biodistribution; pharmaceutics; targeted therapies; gambogic acid; GE11 peptide; formulation and dosage form development; transient modulation; ROESY NMR spectroscopy; bioaccessibility; polymeric micelle; pharmacological Inhibitors of HIF-1 and STAT3; nanoparticles; Vitamin D; drug discovery; EGFR-targeted therapy; translational research; clinical trials; doxorubicin; dissolution; drug development; permeation enhancers; Canada; plant; primary central nervous system lymphomas; photostabilizers; head and neck squamous cell carcinoma; mouse models; drug delivery systems; melphalan; hypoxia-induced chemoresistance; skin; virus; circadian clock; child friendly formulation; adenanthin; co-delivery; canola oil deodorizer distillate; Metaplex; innovation; controlled drug delivery; nifedipine; radiolabeling; amphotericin B; biological barriers; blood-brain barrier (BBB); biologicals; lipid nanoparticles; oral formulation; phytosterols; medical devices; chronotherapy; oral; cationic gemini surfactant; route of administration; drug delivery; intra-arterial chemotherapy; developing world; sustained delivery; water miscible solvents; combination therapy; antibodies; throughput; magnetic fields; liposomes; medulloblastoma; drug-resistant melanoma; rosmarinic acid; topical formulation; TNO gastrointestinal model; gastrointestinal simulator; malignant gliomas; transdermal drug delivery; oral delivery; precision medicine; 3D spheroid; flavonoids; staurosporine; DOX-Vit D; loading gradients; bacteriophage; phospholipid complex; triggered drug release; HIF-1; phage display; pharmacokinetics; emulsion; quercetin; cisplatin; parasitic infections; remote loading; HAV6 cadherin peptide; blood-brain barrier; inclusion complex; tocopherols; STAT3; ultrasound; liposome; fungal infections; magnetic resonance imaging (MRI); MG63; model orange juice; radiation; cancer; mefloquine; small molecules
• Persona (resp. second.): BadeaIldiko; WasanKishor M.
• Sommario/riassunto: Canada continues to have a rich history of ground-breaking research in drug delivery within academic institutions, pharmaceutical industry and the biotechnology community.
• Titolo autorizzato: Drug Delivery Technology Development in Canada
• ISBN: 3-03928-005-8
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910367736503321
• Lo trovi qui: Univ. Federico II